PL407393A1 - New lipoamino acids containing biogenic amino acids and their application - Google Patents

New lipoamino acids containing biogenic amino acids and their application

Info

Publication number
PL407393A1
PL407393A1 PL407393A PL40739314A PL407393A1 PL 407393 A1 PL407393 A1 PL 407393A1 PL 407393 A PL407393 A PL 407393A PL 40739314 A PL40739314 A PL 40739314A PL 407393 A1 PL407393 A1 PL 407393A1
Authority
PL
Poland
Prior art keywords
new
application
amino acids
lipoamino
acids
Prior art date
Application number
PL407393A
Other languages
Polish (pl)
Other versions
PL223050B1 (en
Inventor
Bożena Patkowska-Sokoła
Wiesława Walisiewicz-Niedbalska
Andrzej Wojciech Lipkowski
Robert Bodkowski
Katarzyna Czyż
Original Assignee
Uniwersytet Przyrodniczy we Wrocławiu
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uniwersytet Przyrodniczy we Wrocławiu filed Critical Uniwersytet Przyrodniczy we Wrocławiu
Priority to PL407393A priority Critical patent/PL223050B1/en
Publication of PL407393A1 publication Critical patent/PL407393A1/en
Publication of PL223050B1 publication Critical patent/PL223050B1/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Ujawniono nowe lipoaminokwasy pochodne kwasu ?-eleostearynowego o budowie 9c,11t,13t C18:3 oraz biogennego aminokwasu wybranego z grupy: seryna, tyrozyna, asparagina. Rozwiązanie dotyczy również zastosowania nowych aminokwasów jako środków bioaktywnych do profilaktyki lub wspomagania leczenia lub terapii przeciw nowotworowej.New lipoamino acids derived from α-leostearic acid with the structure 9c, 11t, 13t C18: 3 and a biogenic amino acid selected from the group: serine, tyrosine, asparagine have been disclosed. The solution also applies to the use of new amino acids as bioactive agents for the prevention or support of cancer therapy or therapy.

PL407393A 2014-03-04 2014-03-04 New lipoamino acids containing biogenic amino acids and their application PL223050B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PL407393A PL223050B1 (en) 2014-03-04 2014-03-04 New lipoamino acids containing biogenic amino acids and their application

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL407393A PL223050B1 (en) 2014-03-04 2014-03-04 New lipoamino acids containing biogenic amino acids and their application

Publications (2)

Publication Number Publication Date
PL407393A1 true PL407393A1 (en) 2015-09-14
PL223050B1 PL223050B1 (en) 2016-10-31

Family

ID=54064913

Family Applications (1)

Application Number Title Priority Date Filing Date
PL407393A PL223050B1 (en) 2014-03-04 2014-03-04 New lipoamino acids containing biogenic amino acids and their application

Country Status (1)

Country Link
PL (1) PL223050B1 (en)

Also Published As

Publication number Publication date
PL223050B1 (en) 2016-10-31

Similar Documents

Publication Publication Date Title
PH12017501956A1 (en) Compositions of obeticholic acid and methods of use
TN2018000276A1 (en) Inhibitors of receptor-interacting protein kinase 1.
EA201591743A1 (en) STIMULATORS sGC
MX2018005829A (en) Compositions for treating the hair.
NZ734586A (en) Bicyclic heterocycles as fgfr inhibitors
EA201790273A1 (en) FLAGELLIN COMPOSITIONS AND THEIR APPLICATION
MX2016016666A (en) Boronic acid derivatives and therapeutic uses thereof.
MX2016015093A (en) Boronic acid derivatives and therapeutic uses thereof.
EA201790649A1 (en) BENZE-SUBSTITUTED INDAZOLES AS BUB 1 INHIBITORS
MX2017004838A (en) Interleukin-15 compositions and uses thereof.
CL2016002072A1 (en) 2-amino-3,5,5-trifluoro-3,4,5,6-tetrahydropyridines as bace1 inhibitors for the treatment of Alzheimer's disease
SG10201908028SA (en) Cyclopropylamines as lsd1 inhibitors
EA201691582A1 (en) NEW PHARMACEUTICAL PREPARATIONS
JO3343B1 (en) Novel5-aminotetrahydroquinoline-2-carboxylic acids and their use
EA201692526A1 (en) SUBSTITUTED [1,2,4] TRIAZOLE COMPOUNDS
MX364486B (en) Pyridazinone-amides derivatives.
UY36224A (en) TRICYCLIC COMPOUNDS OF IMIDAZO-PIRIMIDINONA
CL2015002897A1 (en) Bace1 inhibitors
EA201791467A1 (en) AQUEOUS OPHTHALMIC SOLUTION
MX2020006596A (en) Hydroxyisoxazolines and derivatives thereof.
MX2022006817A (en) Formulations/compositions comprising a btk inhibitor.
EA201591055A1 (en) POLYPEPTIDE OF SOLUBLE RECEPTOR 3 FIBROBAL GROWTH FACTOR (FGR3) FOR APPLICATION FOR THE PURPOSE OF PREVENTION OR TREATMENT OF DISTURBANCES ASSOCIATED WITH DECOMPOSITION OF SKELETON GROWTH
MX2018015410A (en) Oxaborole esters and uses thereof.
MX2018002514A (en) Modified cytotoxins and their therapeutic use.
GEP20186893B (en) Pyrazines modulators of gpr6